1 active warrant series covering 11,201,659 shares (~6.3% potential dilution); nearest expiry 2035-07-10.
Compare this book against every issuer →No option grants read from this issuer's latest financial statements. That is not the same as none outstanding — where a filing discloses an option plan we read it, and where it does not, this stays empty rather than printing a zero we cannot source.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
1 active warrant series covering 11,201,659 shares (~6.3% potential dilution); nearest expiry 2035-07-10.
Compare this book against every issuer →No option grants read from this issuer's latest financial statements. That is not the same as none outstanding — where a filing discloses an option plan we read it, and where it does not, this stays empty rather than printing a zero we cannot source.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
